IRIS Institutional Research Information System - AIR Archivio Istituzionale della Ricerca

PODDA, MAURO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 11.642
NA - Nord America 8.453
AS - Asia 7.167
SA - Sud America 733
AF - Africa 188
OC - Oceania 35
Continente sconosciuto - Info sul continente non disponibili 5
Totale 28.223
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 8.159
GB - Regno Unito 4.881
SG - Singapore 2.211
CN - Cina 2.119
IT - Italia 1.783
DE - Germania 1.128
SE - Svezia 967
RU - Federazione Russa 784
HK - Hong Kong 607
BR - Brasile 498
VN - Vietnam 444
FR - Francia 440
UA - Ucraina 396
TR - Turchia 383
NL - Olanda 362
IN - India 361
KR - Corea 315
BD - Bangladesh 261
IE - Irlanda 229
CA - Canada 205
FI - Finlandia 196
EU - Europa 176
JP - Giappone 93
CO - Colombia 88
PL - Polonia 86
ID - Indonesia 77
AR - Argentina 53
ES - Italia 49
CH - Svizzera 47
GR - Grecia 45
DK - Danimarca 44
IQ - Iraq 43
CI - Costa d'Avorio 41
MX - Messico 39
AT - Austria 38
PK - Pakistan 37
BE - Belgio 36
SA - Arabia Saudita 35
AU - Australia 32
EG - Egitto 24
ZA - Sudafrica 24
LU - Lussemburgo 23
PH - Filippine 23
EC - Ecuador 22
NO - Norvegia 20
MA - Marocco 19
VE - Venezuela 19
CL - Cile 16
UZ - Uzbekistan 16
MY - Malesia 15
RO - Romania 15
JO - Giordania 14
PY - Paraguay 13
TW - Taiwan 13
IR - Iran 11
KE - Kenya 11
LT - Lituania 11
NG - Nigeria 10
TH - Thailandia 10
CZ - Repubblica Ceca 9
UY - Uruguay 9
JM - Giamaica 8
AE - Emirati Arabi Uniti 7
BO - Bolivia 7
KZ - Kazakistan 7
LB - Libano 7
LY - Libia 7
NP - Nepal 7
PE - Perù 7
TN - Tunisia 7
HU - Ungheria 6
IL - Israele 6
MK - Macedonia 6
OM - Oman 6
AL - Albania 5
GH - Ghana 5
HN - Honduras 5
QA - Qatar 5
SC - Seychelles 5
TT - Trinidad e Tobago 5
AZ - Azerbaigian 4
BA - Bosnia-Erzegovina 4
BW - Botswana 4
CR - Costa Rica 4
DO - Repubblica Dominicana 4
DZ - Algeria 4
KG - Kirghizistan 4
LK - Sri Lanka 4
MU - Mauritius 4
PR - Porto Rico 4
BN - Brunei Darussalam 3
BS - Bahamas 3
BY - Bielorussia 3
GT - Guatemala 3
KW - Kuwait 3
LA - Repubblica Popolare Democratica del Laos 3
LI - Liechtenstein 3
LV - Lettonia 3
PA - Panama 3
PT - Portogallo 3
Totale 28.323
Salva come PNG Salva come JPEG
Città #
Southend 4.623
Ann Arbor 1.366
Singapore 1.276
Ashburn 755
Hong Kong 572
Chandler 540
Beijing 465
San Jose 437
Milan 433
Seattle 418
Jacksonville 279
Princeton 277
Dallas 272
Council Bluffs 266
Wilmington 261
Frankfurt am Main 235
Dublin 223
Redmond 200
Bengaluru 172
Los Angeles 155
Santa Clara 155
Nanjing 143
Dearborn 138
Fairfield 138
Toronto 135
Mountain View 128
Lauterbourg 125
Sakarya 125
Boardman 123
Ho Chi Minh City 117
New York 116
Moscow 114
Woodbridge 111
Serra 110
Grafing 108
Hefei 107
Buffalo 105
Des Moines 101
Berlin 94
Guangzhou 91
Hanoi 88
Houston 83
Andover 80
Bogotá 79
Somerville 76
Dong Ket 74
Warsaw 72
Rome 71
Columbus 68
Tokyo 67
Shanghai 63
Jinan 59
Shenyang 58
Cangzhou 55
The Dalles 54
Helsinki 50
São Paulo 48
Cambridge 47
Seoul 47
Munich 45
Changsha 42
Jakarta 41
Abidjan 40
Athens 39
Nanchang 38
Tianjin 36
Bitonto 33
Kiez 31
Redwood City 29
Hebei 28
Brussels 27
Hangzhou 27
Phoenix 27
Shenzhen 27
Jiaxing 24
Amsterdam 23
Bologna 23
Fuzhou 23
San Diego 23
Zhengzhou 23
Istanbul 22
Nuremberg 21
Saint Petersburg 21
Boisar 20
Eitensheim 20
Mumbai 20
Turin 20
Da Nang 19
Kunming 19
Ottawa 19
Stockholm 19
Verona 19
Ningbo 18
Paris 18
Zurich 18
Chicago 17
Haiphong 17
Naples 17
Nürnberg 16
Palermo 16
Totale 17.873
Salva come PNG Salva come JPEG
Nome #
Elective surgery system strengthening: development, measurement, and validation of the surgical preparedness index across 1632 hospitals in 119 countries 1.552
Reducing the environmental impact of surgery on a global scale: systematic review and co-prioritization with healthcare workers in 132 countries 603
Apotopes and the biliary specificity of primary biliary cirrhosis 469
Anti-mitochondrial antibodies and reactivity to N. aromaticivorans proteins in Icelandic patients with primary biliary cirrhosis and relatives 380
X chromosome monosomy : a common mechanism for autoimmune diseases 361
International genome-wide meta-analysis identifies new primary biliary cirrhosis risk loci and targetable pathogenic pathways 355
Peculiar HLA polymorphisms in Italian patients with primary biliary cirrhosis 349
Pathway-based analysis of primary biliary cirrhosis genome-wide association studies 326
Preferential X chromosome loss but random inactivation characterize primary biliary cirrhosis 317
Telomere dysfunction in peripheral blood mononuclear cells from patients with primary biliary cirrhosis 315
A short version of a HRQoL questionnaire for Italian and Japanese patients with Primary Biliary Cirrhosis 312
Autophagy : highlighting a novel player in the autoimmunity scenario 306
The consequences of apoptosis in autoimmunity 306
Primary biliary cirrhosis in monozygotic and dizygotic twins : genetics, epigenetics, and environment 303
Antinuclear antibodies in primary biliary cirrhosis 296
Antibody to carbonic anhydrase II is present in primary biliary cirrhosis (PBC) irrespective of antimitochondrial antibody status 294
Hypercholesterolaemia is not associated with early atherosclerotic lesions in primary biliary cirrhosis 291
Current approach to loop ileostomy closure: a nationwide survey on behalf of the Italian Society of ColoRectal Surgery (SICCR) 287
Epidemiology and pathogenesis of primary biliary cirrhosis 287
PROsthetic MEsh Reinforcement in elective minimally invasive paraesophageal hernia repair (PROMER): an international survey 285
X monosomy in female systemic lupus erythematosus 285
A minimally invasive technique for the evaluation of the regulatory steps of the two major pathways of bile acid synthesis 276
Acute liver and renal failure during treatment with buprenorphine at therapeutic dose 268
Classical HLA-DRB1 and DPB1 alleles account for HLA associations with primary biliary cirrhosis 267
Antibodies to carbonic anhydrase II in antimitochondrial antibody-negative primary biliary cirrhosis: a negative study 266
The enigma of primary biliary cirrhosis 263
Treatment with PEG-interferon and ribavirin for chronic hepatitis C increases neutrophil and monocyte chemotaxis 263
Comparison of the clinical features and clinical course of antimitochondrial antibody-positive and -negative primary biliary cirrhosis 258
Males with primary biliary cirrhosis manifest enhanced rates of Y chromosome loss compared to healthy subjects 253
Autoantibodies against nuclear pore complexes are associated with more active and severe liver disease in primary biliary cirrhosis 253
Frequency of monosomy X in women with primary biliary cirrhosis 252
Decreased serum leptin levels in primary biliary cirrhosis : a link between metabolism and autoimmunity? 252
T-cell receptor polymorphism in primary biliary cirrhosis 252
Correlation of initial autoantibody profile and clinical outcome in primary biliary cirrhosis 248
Decrease and dysfunction of dendritic cells correlate with impaired HCV-specific CD4+T-cell proliferation in patients with HCV-infection 247
Geographic clusters of primary biliary cirrhosis 244
Genome-wide analysis of DNA methylation, copy number variation, and gene expression in monozygotic twins discordant for primary biliary cirrhosis 243
Analysis of fatiguability in patients affected by Primary Biliary Cirrhosis by means of Transcranial Magnetic Stimulation 239
Y chromosome loss in male patients with primary biliary cirrhosis 236
Vitamin D receptor polymorphisms are associated with increased susceptibility to primary biliary cirrhosis in Japanese and Italian populations 234
Exacerbation of chronic hepatitis D during interferon alpha administration 229
Genetic variants of the endothelial nitric oxide synthase in patients with primary biliary cirrhosis: Association with disease severity 224
Neurophysiology of fatigue in primary biliary cirrhosis suggests a central origin and a motivational impairment 224
Blood fetal microchimerism in primary biliary cirrhosis 224
[Reynolds syndrome. First Italian epidemiologic data] 221
Treatment with PEG-interferon and ribavirin for chronic hepatitis C does not decrease neutrophil and monocyte activity 219
Imparare a raccogliere l'anamnesi in una prospettiva narrative-based : Un'esperienza basata sulla scrittura autobiografica degli studenti di medicina 218
TNF-alpha polymorphisms in primary biliary cirrhosis: a northern and southern Italian experience 216
Primary biliary cirrhosis : solving the enigma 215
Patients with primary biliary cirrhosis do not show post-exercise depression of cortical excitability 215
Lithogenic bile after conjugated estrogen 214
Males with primary biliary cirrhosis manifest enhanced rates of Y chromosome loss in peripheral white blood cells 211
Human leukocyte antigen polymorphisms in Italian primary biliary cirrhosis : a multicenter study of 664 patients and 1992 healthy controls 210
Severe hepatic encephalopathy in a patient with liver cirrhosis after administration of angiotensin-converting enzyme inhibitor/angiotensin II receptor blocker combination therapy : a case report 205
Ursodeoxycholic and tauro-ursodeoxycholic acids for the treatment of primary biliary cirrhosis: a pilot crossover study 204
Global overview of the management of acute cholecystitis during the COVID-19 pandemic (CHOLECOVID study) 199
Interpreting serological tests in diagnosing autoimmune liver diseases 198
HLA-DRB1 and Tumor Necrosis Factor A but not Cystic Fibrosis Transmembrane Conductance Regulator genes contribute to the genetic susceptibility of Primary Sclerosing Cholangitis 198
Genetics and geoepidemiology of primary biliary cirrhosis : following the footprints to disease etiology 197
The relevance of immune reactions in acute favism 196
Effects of a preparation containing a standardized ginseng extract combined with trace elements and multivitamins against hepatotoxin-induced chronic liver disease in the elderly 194
Changes in classic and alternative pathways of bile acid synthesis in chronic liver disease 193
A sensitive bead assay for antimitochondrial antibodies : Chipping away at AMA-negative primary biliary cirrhosis 191
Serum levels of soluble interleukin 2 receptor a in patients with primary biliary cirrhosis 190
PBC screen : an IgG/IgA dual isotype ELISA detecting multiple mitochondrial and nuclear autoantibodies specific for primary biliary cirrhosis 186
A combination of chenodeoxycholic acid and ursodeoxycholic acid is more effective than either alone in reducing biliary cholesterol saturation 186
Clinical significance of hepatic HCV RNA in patients with chronic hepatitis C demonstrating long-term sustained response to interferon-alpha therapy 185
Chenodeoxycholic acid and ursodeoxycholic acid effects in endogenous hypertriglyceridemias. A controlled double-blind trial 184
Bile acid-induced inhibition of the lymphoproliferative response to phytohemagglutinin and pokeweed mitogen: an in vitro study 183
Sustained response to combination therapy in patients with chronic hepatitis C who failed to respond to interferon 182
A case of congenital peripheral primitive neuroectodermal tumor presenting with multiple metastases 182
Soluble CD40L in plasma of patients with primary biliary cirrhosis 180
Antibodies to hepatitis C virus in primary biliary cirrhosis 179
Skewing of X chromosome inactivation in autoimmunity 178
Role of ABCB4 gene mutations in hepatobiliary diseases of the adult : the experience of a liver Unit in Milan 178
Inadequate dietary intake but not renal tubular acidosis is associated with bone demineralization in primary biliary cirrhosis 178
SNP analysis of genes implicated in T cell proliferation in primary biliary cirrhosis 177
Gastrointestinal tolerability of ibuprofen administered in two pharmaceutical formulations 177
Is autoimmunity a matter of sex? 176
Patients with primary biliary cirrhosis react against a ubiquitous xenobiotic-metabolizing bacterium 174
LAPAROSCOPY WITH LAPAROSCOPIC ULTRASOUND FOR PRETREATMENT STAGING OF HEPATOCELLULAR CARCINOMA : A PROSPECTIVE STUDY 173
Genes and (auto)immunity in primary biliary cirrhosis 172
Keratin variants are overrepresented in primary biliary cirrhosis and associate with disease severity 170
Lack of immunological or molecular evidence for a role of mouse mammary tumor retrovirus in primary biliary cirrhosis 168
Primary biliary cirrhosis : does X mark the spot? 168
null 165
Ten-year combination treatment with colchicine and ursodeoxycholic acid for primary biliary cirrhosis: a double-blind, placebo-controlled trial on symptomatic patients 163
Interferon alpha and its contribution to autoimmunity 161
The limitations and hidden gems of the epidemiology of primary biliary cirrhosis 161
Genetic polymorphisms influencing xenobiotic metabolism and transport in patients with primary biliary cirrhosis 160
Genes and goals : an approach to microarray analysis in autoimmunity 159
Gallstone dissolution after 6 months of ursodeoxycholic acid (UDCA): effectiveness of different doses 159
HLA-DRB1 polymorphisms in 676 Italian patients with primary biliary cirrhosis and 2028 matched healthy controls : a nation-wide population-based case-control study 155
Primary biliary cirrhosis is not an additional risk factor for bone loss in women receiving regular calcium and vitamin D supplementation. A controlled longitudinal study 155
Clinical features and management of primary biliary cirrhosis 155
Effect of different doses of ursodeoxycholic acid in chronic liver disease 155
Common variants of the matrix metalloproteinase-3 (stromelysin) gene promoter in primary biliary cirrhosis 154
Ursodeoxycholic acid for chronic liver diseases 152
Peripheral blood cell disfunction in patients with chronic HCV infection 151
Prevalence of GB virus-C/hepatitis G virus infection in patients with cryptogenic chronic liver disease and in patients with primary biliary cirrhosis or Wilson's disease 150
Totale 24.189
Salva come PNG Salva come JPEG
Categoria #
all - tutte 68.437
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 68.437
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021240 0 0 0 0 0 0 0 0 0 0 0 240
2021/20222.376 235 193 120 228 143 170 165 131 267 233 201 290
2022/20232.187 287 229 132 284 223 356 77 136 223 39 85 116
2023/20241.762 188 165 64 96 362 130 104 129 67 113 156 188
2024/20253.334 158 354 86 310 224 176 156 342 175 304 313 736
2025/20267.333 669 441 842 551 813 530 832 486 754 584 554 277
Totale 29.445